Similar articles

• Effects of physostigmine doses (0.1 mg, 0.3 mg, 0.6 mg) on the blood pressure, the body temperature and the heart rate in man.

  Hrbek J, Macáková J, Komenda S, Siroká A, Rypka M. Hrbek J, et al. Acta Univ Palacki Olomuc Fac Med. 1985;112:263-77. Acta Univ Palacki Olomuc Fac Med. 1985. PMID: 2938437 No abstract available.
• On acute effects of some drugs on the higher nervous activity in man. Scopolamine (0.6 mg), physostigmine (1.0 mg) and their interaction. Part LIII.

  Hrbek J, Macáková J, Komenda S, Siroká A, Rypka M. Hrbek J, et al. Acta Univ Palacki Olomuc Fac Med. 1985;112:185-226. Acta Univ Palacki Olomuc Fac Med. 1985. PMID: 2938435 No abstract available.
• Effects of physostigmine (1.0 mg s.c.) and scopolamine (0.6 mg s.c., applied 15 and 30 minutes after physostigmine) on the blood pressure, the body temperature, and the heart rate in man.

  Hrbek J, Macáková J, Komenda S, Siroká A, Hrbek J Jr. Hrbek J, et al. Acta Univ Palacki Olomuc Fac Med. 1986;115:73-89. Acta Univ Palacki Olomuc Fac Med. 1986. PMID: 2951977 No abstract available.
• On acute effects of some drugs on the higher nervous activity in man. Physostigmine (0.1 mg, 0.3 mg, 0.6 mg). Part LIV.

  Hrbek J, Macáková J, Komenda S, Siroká A, Dostálová K. Hrbek J, et al. Acta Univ Palacki Olomuc Fac Med. 1985;112:227-62. Acta Univ Palacki Olomuc Fac Med. 1985. PMID: 2938436 No abstract available.
• The central effects of scopolamine in man.

  Safer DJ, Allen RP. Safer DJ, et al. Biol Psychiatry. 1971;3(4):347-55. Biol Psychiatry. 1971. PMID: 4950489 Review. No abstract available.